Bupropion Hydrochloride (XL)
NDC 82868-097, bupropion hydrochloride, tablet, film coated, extended release, from Northwind Health Company, LLC.
- Product NDC
- 82868-097
- Status
- Listed
- Labeler
- Northwind Health Company, LLC
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207479
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82868-097 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPROPION HYDROCHLORIDE150 mg/1
Pharmacologic classes
Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82868-097-96 | 82868009796 | 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-097-96) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4ddf6ba2-c020-7912-e063-6394a90a7964
Use it
Look up 82868-097 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82868-097 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82868-097. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.